Patent: 8,315,818
✉ Email this page to a colleague
Summary for Patent: 8,315,818
| Title: | Methods of diagnosing inflammatory bowel disease |
| Abstract: | The present invention provides methods, systems, and code for accurately classifying whether a sample from an individual is associated with inflammatory bowel disease (IBD) or a clinical subtype thereof. In particular, the present invention is useful for classifying a sample from an individual as an IBD sample using a statistical algorithm and/or empirical data. The present invention is also useful for differentiating between a clinical subtype of IBD such as Crohn\'s disease (CD) and ulcerative colitis (UC) using a statistical algorithm and/or empirical data. Thus, the present invention provides an accurate diagnostic prediction of IBD or a clinical subtype thereof and prognostic information useful for guiding treatment decisions. |
| Inventor(s): | Lois; Augusto (San Diego, CA), Neri; Bruce (Carlsbad, CA) |
| Assignee: | Nestec S.A. (Vevey, CH) |
| Application Number: | 12/965,512 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,315,818
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Octapharma Pharmazeutika Produktionsges.m.b.h. | CUTAQUIG | immune globulin subcutaneous (human)-hipp | Solution | 125668 | 12/12/2018 | ⤷ Try a Trial | 2025-12-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
